ONO-RS-531

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameONO-RS-531

Drug Alias NameCysLT receptor 1/CysLT receptor 2 antagonists (Ono Pharmaceuticals)CysLT1/CysLT2 antagonists (Ono Pharmaceuticals)cysteinyl leukotriene 1 and 2 receptor antagonists (Ono Pharmaceuticals)ONO-RS-531

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCysteinyl leukotriene receptor 1 antagonistsCysteinyl Leukotriene Receptor 2 antagonists

TargetsCysteinyl leukotriene receptor 1Cysteinyl Leukotriene Receptor 2

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOno Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOno Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsAsthma

Other Information

ATC CodeN/A